Kidney Disease: Acute Kidney Injury.
Journal
FP essentials
ISSN: 2159-3000
Titre abrégé: FP Essent
Pays: United States
ID NLM: 101578821
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
16
10
2021
Statut:
ppublish
Résumé
Acute kidney injury (AKI) is characterized by an abrupt decrease in renal function or the onset of frank renal failure. Kidney Disease: Improving Global Outcomes (KDIGO) defines AKI as an increase in the serum creatinine (SCr) level of 0.3 mg/dL or more within 48 hours, an SCr level increase of 1.5 times or more of the baseline level within 7 days, or a decrease in urine output to less than 0.5 mL/kg/hour for 6 hours. AKI severity is determined by the degree of SCr increase or decrease in urine output. AKI typically is caused by systemic illness or toxic exposure. Thus, determining the cause is critical when possible. The history should focus on risk factors, including nephrotoxic drugs. The physical examination should include determination of fluid volume status. Urinalysis with microscopy can narrow the differential diagnosis. AKI management includes control of the underlying cause, achievement and maintenance of euvolemia, nutritional optimization, blood glucose control, and pharmacotherapy. Treatment with fluid resuscitation or diuresis is guided by the volume status. Emergent referral to a nephrology subspecialist is recommended for patients with stage 2 or 3 AKI; patients with stage 1 AKI and a concomitant, decompensated condition; or if the etiology of the AKI is unclear. Urgent referral should be considered if the injury does not improve with treatment or if glomerulonephritis is suspected.
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-19Informations de copyright
Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.